Thus, the objective of our work was to analyse the expression of CD39 in PBMCs from relapsing RR-MS patients and age- and sex-paired healthy subjects, with a special focus on the expression of CD39 on Treg cells. Here, ENTPD1 is linked to myeloid sarcoma.